Foundation Medicine Sets Terms for $75 Million IPO

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Foundation Medicine, which develops diagnostic systems that assess genomic alterations in cancer cells and match patients with targeted therapies, announced terms for its IPO on Thursday. The Cambridge, MA-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Foundation Medicine would command a fully diluted market value of $421 million.

Help employers find you! Check out all the jobs and post your resume.

Back to news